QDEL
Price
$14.37
Change
+$0.24 (+1.70%)
Updated
Jun 15, 12:29 PM (EDT)
Capitalization
963.54M
45 days until earnings call
Intraday BUY SELL Signals
XRAY
Price
$10.18
Change
+$0.09 (+0.89%)
Updated
Jun 15, 12:34 PM (EDT)
Capitalization
2.02B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QDEL vs XRAY

Header iconQDEL vs XRAY Comparison
Open Charts QDEL vs XRAYBanner chart's image
QDEL vs XRAY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
QDEL vs. XRAY commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QDEL is a Hold and XRAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2026
Stock price -- (QDEL: $14.13 vs. XRAY: $10.09)
Brand notoriety: QDEL and XRAY are both not notable
QDEL represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: QDEL: 50% vs. XRAY: 67%
Market capitalization -- QDEL: $963.54M vs. XRAY: $2.02B
QDEL [@Medical/Nursing Services] is valued at $963.54M. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.02B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $153.59B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $145.58B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.43B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QDEL’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • QDEL’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, QDEL is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QDEL’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • QDEL’s TA Score: 5 bullish, 4 bearish.
  • XRAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than QDEL.

Price Growth

QDEL (@Medical/Nursing Services) experienced а -1.40% price change this week, while XRAY (@Pharmaceuticals: Other) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.62%. For the same industry, the average monthly price growth was +4.82%, and the average quarterly price growth was -13.53%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +12.88%. For the same industry, the average monthly price growth was +13.20%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

QDEL is expected to report earnings on Jul 30, 2026.

XRAY is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+12.88% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.02B) has a higher market cap than QDEL($964M). XRAY YTD gains are higher at: -11.724 vs. QDEL (-50.525). XRAY has higher annual earnings (EBITDA): -127M vs. QDEL (-541.8M). XRAY has more cash in the bank: 190M vs. QDEL (140M). XRAY has less debt than QDEL: XRAY (2.33B) vs QDEL (2.88B). XRAY has higher revenues than QDEL: XRAY (3.68B) vs QDEL (2.66B).
QDELXRAYQDEL / XRAY
Capitalization964M2.02B48%
EBITDA-541.8M-127M427%
Gain YTD-50.525-11.724431%
P/E RatioN/AN/A-
Revenue2.66B3.68B72%
Total Cash140M190M74%
Total Debt2.88B2.33B123%
FUNDAMENTALS RATINGS
QDEL vs XRAY: Fundamental Ratings
QDEL
XRAY
OUTLOOK RATING
1..100
3213
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
1884
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (2) in the Medical Specialties industry is somewhat better than the same rating for QDEL (37). This means that XRAY’s stock grew somewhat faster than QDEL’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

XRAY's SMR Rating (99) in the Medical Specialties industry is in the same range as QDEL (99). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's Price Growth Rating (62) in the Medical Specialties industry is in the same range as XRAY (63). This means that QDEL’s stock grew similarly to XRAY’s over the last 12 months.

QDEL's P/E Growth Rating (18) in the Medical Specialties industry is significantly better than the same rating for XRAY (84). This means that QDEL’s stock grew significantly faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QDELXRAY
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
53%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 8 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 13 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
59%
Aroon
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
QDEL
Daily Signal:
Gain/Loss:
XRAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGIAX14.580.10
+0.69%
Goldman Sachs Global Infras A
ARTTX27.900.19
+0.69%
Artisan Focus Fund Investor
TMCPX57.060.28
+0.49%
Touchstone Mid Cap Y
VWELX46.890.17
+0.36%
Vanguard Wellington Inv
BLNAX14.720.05
+0.34%
Meeder Balanced Adviser

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
+0.28%
AZTA - QDEL
51%
Loosely correlated
+0.58%
XRAY - QDEL
50%
Loosely correlated
-0.49%
RVTY - QDEL
50%
Loosely correlated
-1.83%
DHR - QDEL
49%
Loosely correlated
-0.38%
A - QDEL
48%
Loosely correlated
+0.22%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.49%
NVST - XRAY
63%
Loosely correlated
+0.41%
ALGN - XRAY
51%
Loosely correlated
-0.95%
QDEL - XRAY
50%
Loosely correlated
+0.28%
KIDS - XRAY
48%
Loosely correlated
-0.06%
BAX - XRAY
46%
Loosely correlated
+1.81%
More